Evgenii Chekalin

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Ibrutinib blocks YAP1 activation and reverses BRAFi resistance in melanoma cells”.

Ibrutinib blocks YAP1 activation and reverses BRAFi resistance in melanoma cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.25.006916

N/A

0DataRank · unranked

1 citations

PA Newbury, Evgenii Chekalin, Shreya Paithankar, AI Doseff, Bo Chen +3 more

Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells

Molecular Pharmacology(2021)10.1124/molpharm.121.000331

N/A

0DataRank · unranked

16 citations

Patrick Newbury, Evgenii Chekalin, Shreya Paithankar, Andrea I. Doseff, BIN CHEN +3 more

Clinical genome sequencing in patients with suspected rare genetic disease in Peru

npj Genomic Medicine(2024)10.1038/s41525-024-00434-8

N/A

0DataRank · unranked

4 citations

Mario Cornejo‐Olivas, Milagros Dueñas, Nelson Purizaca‐Rosillo, Richard Rodríguez, Karina Milla‐Neyra +45 more